Sep 21, 2026 9 0
Uploaded by Seraphina
Favorite
Share
More Options
17
A novel regulatory axis of MSI2-AGO2/miR-30a-3p-CGRRF1 drives cancer chemoresistance by upregulating the KRAS/ERK pathway_Page 1

Open in WPS to view all 17 pages